A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
By Ying-hui Jin, Lin Cai, Zhenshun Cheng, Hong Cheng, Tong Deng, Yipin Fan, Cheng Fang, Di Huang, Lu‐qi Huang, Qiao Huang and 36 more. Military Medical Research, 2020
2,153 citations recorded by the source corpus.
In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named “2019 novel coronavirus (2019-nCoV)” by the World Health Organization (WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly, it attracted the world’s attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management, an evidence-based guideline urgently needs to be developed. Therefore, we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development; we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology, epidemiological characteristics, disease screening and population prevention, diagnosis, treatment and control (including traditional Chinese Medicine), nosocomial infection prevention and control, and disease nursing of the 2019-nCoV. Moreover, we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV.
Subfields: Infectious Diseases, Neurology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/ffcb72db2bdc177286d0991ab404cee4dd12eb2d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak (2020, neutral): “A guideline was published for the medical sta ff , healthcare providers, and, public health individuals and researchers who are interested in the 2019 nCoV [29].”
- The Role of Imaging in the Detection and Management of COVID-19: A Review (2020, background): “The above mentioned CT characteristics have got extensive attention from the clinicians [21].”
- The SARS-CoV-2 outbreak: What we know (2020, methodology): “In addition, it should be distinguished from non-infectious diseases, such as vasculitis, dermatomyositis, and organizing pneumonia([9]).”
- Coronavirus disease 2019 (COVID-19): A literature review (2020, neutral): “Radiology findings Radiology finding may vary with patients age, disease progression, immunity status, comorbidity, and initial medical intervention [53].”
- Artificial Intelligence (AI) and Big Data for Coronavirus (COVID-19) Pandemic: A Survey on the State-of-the-Arts (2020, neutral): “Interestingly, the recent work in [118] presented a comprehensive guideline with useful tools to serve the diagnosis and treatment of COVID-19.”
- Effects of COVID-19 pandemic in daily life (2020, neutral): “Most of the countries have slowed down their manufacturing of the products 3 This COVID-19 has affected the sources of supply and effects the global economy.”